MDClone's customers are large, data-heavy organizations: academic medical centers, government health agencies, payers, and life-science companies. Named users include Washington University School of Medicine in St. Louis, Intermountain Healthcare, the Regenstrief Institute, the VHA Innovation Ecosystem, the National Institutes of Health, The Ottawa Hospital, and Jewish General Hospital - alongside effectively the whole Israeli healthcare system.
What sets it apart from de-identification tools, data warehouses, and honest-broker programs is the synthetic layer. De-identified data still carries re-identification risk and heavy governance; synthetic data sidesteps the patient entirely, which is what makes cross-organization sharing practical.
Competitors in the broader real-world-data space include Datavant, TriNetX, Truveta, Palantir's health offerings, and Health Catalyst. MDClone's differentiator is pairing self-service exploration with privacy-preserving synthetic output in one platform, aimed at front-line users rather than only specialists.
The business model is B2B enterprise SaaS: recurring platform licensing plus implementation, with provider-to-life-science collaboration as an expansion path. Data providers estimate annual revenue near $21.7M, a figure the company has not officially confirmed.
